<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/oai-pmh.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-09-22T10:43:46Z</responseDate>
  <request identifier="oai:www.ideals.illinois.edu:2142/129179" metadataPrefix="etdms" verb="GetRecord">https://www.ideals.illinois.edu/oai-pmh</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:www.ideals.illinois.edu:2142/129179</identifier>
        <datestamp>2025-10-20</datestamp>
        <setSpec>col_2142_5131</setSpec>
        <setSpec>col_2142_16405</setSpec>
        <setSpec>com_2142_5130</setSpec>
        <setSpec>com_2142_16404</setSpec>
        <setSpec>com_2142_14833</setSpec>
      </header>
      <metadata>
        <thesis xmlns="http://www.ndltd.org/standards/metadata/etdms/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.ndltd.org/standards/metadata/etdms/1.1/ http://www.ndltd.org/standards/metadata/etdms/1.1/etdms11.xsd http://purl.org/dc/elements/1.1/ http://www.ndltd.org/standards/metadata/etdms/1.1/etdmsdc.xsd">
          <dc:format>application/pdf</dc:format>
          <dc:language>en</dc:language>
          <dc:type>text</dc:type>
          <dc:description>Submission original under an indefinite embargo labeled 'Open Access'. The submission was exported from vireo on 2025-10-19 without embargo terms</dc:description>
          <dc:description>The student, Aimee Pepper, accepted the attached license on 2025-03-18 at 11:45.</dc:description>
          <dc:description>The student, Aimee Pepper, submitted this Thesis for approval on 2025-03-18 at 11:54.</dc:description>
          <dc:description>This Thesis was approved for publication on 2025-03-20 at 10:36.</dc:description>
          <dc:description>DSpace SAF Submission Ingestion Package generated from Vireo submission #21683 on 2025-10-19 at 18:09:10</dc:description>
          <dc:title>Clinical validation of SARS-CoV-2 RT-LAMP in animals</dc:title>
          <dc:creator>Pepper, Aimee W.</dc:creator>
          <dc:date>2025-03-20</dc:date>
          <dc:contributor>Wang, Leyi</dc:contributor>
          <dc:contributor>Samuelson, Jonathan P</dc:contributor>
          <dc:contributor>Sander, William E</dc:contributor>
          <dc:subject>SARS-CoV-2</dc:subject>
          <dc:subject>RT-LAMP</dc:subject>
          <dc:subject>rRT-PCR</dc:subject>
          <dc:subject>feces</dc:subject>
          <dc:subject>animals</dc:subject>
          <dc:language>eng</dc:language>
          <dc:description>The wide host range, pathogenicity, and zoonotic potential of SARS-CoV-2 infection in animals highlights the need for additional surveillance strategies. Shedding of SARS-CoV-2 RNA within the intestinal tract is prolonged during animal infection, suggesting that surveillance could be accomplished non-invasively through nucleic acid amplification of animal feces. We validated a commercial, pH-based, colorimetric, RT-LAMP assay for the detection of SARS-CoV-2 RNA in animal feces, with comparison to the gold standard assay, rRT-PCR. The limit of detection of the RT-LAMP assay was 72 genome copies per reaction. RT-LAMP was highly specific for SARS-CoV-2 and did not detect other human or animal coronaviruses. RT-LAMP was robust, with valid results generated for incubation lengths of 30 to 45 minutes, incubation temperatures of 60 to 70°C, and reaction volumes of 10 to 25 µL. The diagnostic sensitivity was 100% for clinical fecal samples with high viral loads (Ct ≤25), 97.4% for samples with moderate-to-high viral loads (Ct ≤33), and 62% overall (Ct ≤40). The diagnostic specificity was 97.9% overall. Blinded method testing organized by an independent laboratory confirmed the reproducibility of the assay. SARS-CoV-2 RNA could still be detected by RT-LAMP following storage of fecal suspensions with moderate-to-high or high viral loads at -80°C, -20°C, 4°C, or room temperature for up to 28 days. To our knowledge, this study represents the first clinical evaluation of RT-LAMP for SARS-CoV-2 RNA detection in animal samples. RT-LAMP testing could detect SARS-CoV-2 infection more rapidly and at the point-of-care in animals with moderate-to-high viral loads that are likely to be infectious, allowing for earlier implementation of quarantine and control measures to limit viral spread and therapeutic interventions to reduce animal mortality.</dc:description>
          <dc:date>2025-05</dc:date>
          <dc:type>Thesis</dc:type>
          <dc:identifier>https://hdl.handle.net/2142/129179</dc:identifier>
          <dc:rights>Copyright 2025 Aimee Pepper</dc:rights>
          <degree>
            <department>Vet Clinical Medicine</department>
            <discipline>VMS-Veterinary Clinical Medcne</discipline>
            <grantor>University of Illinois Urbana-Champaign</grantor>
            <name>M.S.</name>
            <level>Thesis</level>
          </degree>
        </thesis>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
